RAC 1.11% $1.83 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-163

  1. 1,510 Posts.
    lightbulb Created with Sketch. 378
    It really makes it easy to visualise doesn’t it, it sadly I can’t take credit for making it.
    Basically RAC all stage 2 in the preclinical & clinical early stages.

    Just to get Bisantrene to this stage is indeed fortunate especially after being shelved/abandoned at one stage before RAC picked it back up. Thankfully due to previous trials & safety data in humans RAC have a massive headstart & have saved 100s of millions of dollars.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.